<level0 name =" General disorders and administration site">
<level1 name =" Administration site reactions">
<level2 name =" Administration site reactions NEC">
<level3>
Administration site abscess
</level3>
<level3>
Administration site abscess sterile
</level3>
<level3>
Administration site anaesthesia
</level3>
<level3>
Administration site atrophy
</level3>
<level3>
Administration site bruise
</level3>
<level3>
Administration site calcification
</level3>
<level3>
Administration site cellulitis
</level3>
<level3>
Administration site coldness
</level3>
<level3>
Administration site cyst
</level3>
<level3>
Administration site dermatitis
</level3>
<level3>
Administration site discharge
</level3>
<level3>
Administration site discolouration
</level3>
<level3>
Administration site discomfort
</level3>
<level3>
Administration site dryness
</level3>
<level3>
Administration site dysaesthesia
</level3>
<level3>
Administration site eczema
</level3>
<level3>
Administration site erosion
</level3>
<level3>
Administration site erythema
</level3>
<level3>
Administration site exfoliation
</level3>
<level3>
Administration site extravasation
</level3>
<level3>
Administration site fibrosis
</level3>
<level3>
Administration site granuloma
</level3>
<level3>
Administration site haematoma
</level3>
<level3>
Administration site haemorrhage
</level3>
<level3>
Administration site hyperaesthesia
</level3>
<level3>
Administration site hypersensitivity
</level3>
<level3>
Administration site hypertrichosis
</level3>
<level3>
Administration site hypertrophy
</level3>
<level3>
Administration site hypoaesthesia
</level3>
<level3>
Administration site indentation
</level3>
<level3>
Administration site induration
</level3>
<level3>
Administration site infection
</level3>
<level3>
Administration site inflammation
</level3>
<level3>
Administration site injury
</level3>
<level3>
Administration site irritation
</level3>
<level3>
Administration site ischaemia
</level3>
<level3>
Administration site joint discomfort
</level3>
<level3>
Administration site joint effusion
</level3>
<level3>
Administration site joint erythema
</level3>
<level3>
Administration site joint infection
</level3>
<level3>
Administration site joint inflammation
</level3>
<level3>
Administration site joint movement impairment
</level3>
<level3>
Administration site joint pain
</level3>
<level3>
Administration site joint warmth
</level3>
<level3>
Administration site laceration
</level3>
<level3>
Administration site lymphadenopathy
</level3>
<level3>
Administration site macule
</level3>
<level3>
Administration site mass
</level3>
<level3>
Administration site movement impairment
</level3>
<level3>
Administration site necrosis
</level3>
<level3>
Administration site nerve damage
</level3>
<level3>
Administration site nodule
</level3>
<level3>
Administration site odour
</level3>
<level3>
Administration site oedema
</level3>
<level3>
Administration site pain
</level3>
<level3>
Administration site pallor
</level3>
<level3>
Administration site papule
</level3>
<level3>
Administration site paraesthesia
</level3>
<level3>
Administration site phlebitis
</level3>
<level3>
Administration site photosensitivity reaction
</level3>
<level3>
Administration site plaque
</level3>
<level3>
Administration site pruritus
</level3>
<level3>
Administration site pustule
</level3>
<level3>
Administration site rash
</level3>
<level3>
Administration site reaction
</level3>
<level3>
Administration site recall reaction
</level3>
<level3>
Administration site scab
</level3>
<level3>
Administration site scar
</level3>
<level3>
Administration site streaking
</level3>
<level3>
Administration site swelling
</level3>
<level3>
Administration site thrombosis
</level3>
<level3>
Administration site ulcer
</level3>
<level3>
Administration site urticaria
</level3>
<level3>
Administration site vasculitis
</level3>
<level3>
Administration site vesicles
</level3>
<level3>
Administration site warmth
</level3>
<level3>
Malabsorption from administration site
</level3>
<level3>
Oral administration complication
</level3>
<level3>
Puncture site abscess
</level3>
<level3>
Puncture site discharge
</level3>
<level3>
Puncture site erythema
</level3>
<level3>
Puncture site haemorrhage
</level3>
<level3>
Puncture site hernia
</level3>
<level3>
Puncture site hypoaesthesia
</level3>
<level3>
Puncture site induration
</level3>
<level3>
Puncture site infection
</level3>
<level3>
Puncture site oedema
</level3>
<level3>
Puncture site pain
</level3>
<level3>
Puncture site reaction
</level3>
<level3>
Puncture site swelling
</level3>
<level3>
Systemic leakage
</level3>
<level3>
Vessel puncture site anaesthesia
</level3>
<level3>
Vessel puncture site bruise
</level3>
<level3>
Vessel puncture site cellulitis
</level3>
<level3>
Vessel puncture site discharge
</level3>
<level3>
Vessel puncture site erythema
</level3>
<level3>
Vessel puncture site haematoma
</level3>
<level3>
Vessel puncture site haemorrhage
</level3>
<level3>
Vessel puncture site hypoaesthesia
</level3>
<level3>
Vessel puncture site induration
</level3>
<level3>
Vessel puncture site infection
</level3>
<level3>
Vessel puncture site inflammation
</level3>
<level3>
Vessel puncture site occlusion
</level3>
<level3>
Vessel puncture site pain
</level3>
<level3>
Vessel puncture site paraesthesia
</level3>
<level3>
Vessel puncture site phlebitis
</level3>
<level3>
Vessel puncture site pruritus
</level3>
<level3>
Vessel puncture site rash
</level3>
<level3>
Vessel puncture site reaction
</level3>
<level3>
Vessel puncture site swelling
</level3>
<level3>
Vessel puncture site thrombosis
</level3>
<level3>
Vessel puncture site vesicles
</level3>
</level2>
<level2 name =" Application and instillation site reactions">
<level3>
Application site abscess
</level3>
<level3>
Application site abscess sterile
</level3>
<level3>
Application site acne
</level3>
<level3>
Application site alopecia
</level3>
<level3>
Application site anaesthesia
</level3>
<level3>
Application site atrophy
</level3>
<level3>
Application site bruise
</level3>
<level3>
Application site burn
</level3>
<level3>
Application site calcification
</level3>
<level3>
Application site cellulitis
</level3>
<level3>
Application site coldness
</level3>
<level3>
Application site cyst
</level3>
<level3>
Application site dermatitis
</level3>
<level3>
Application site discharge
</level3>
<level3>
Application site discolouration
</level3>
<level3>
Application site discomfort
</level3>
<level3>
Application site dryness
</level3>
<level3>
Application site dysaesthesia
</level3>
<level3>
Application site eczema
</level3>
<level3>
Application site erosion
</level3>
<level3>
Application site erythema
</level3>
<level3>
Application site exfoliation
</level3>
<level3>
Application site extravasation
</level3>
<level3>
Application site fibrosis
</level3>
<level3>
Application site fissure
</level3>
<level3>
Application site folliculitis
</level3>
<level3>
Application site granuloma
</level3>
<level3>
Application site haematoma
</level3>
<level3>
Application site haemorrhage
</level3>
<level3>
Application site hyperaesthesia
</level3>
<level3>
Application site hypersensitivity
</level3>
<level3>
Application site hypertrichosis
</level3>
<level3>
Application site hypertrophy
</level3>
<level3>
Application site hypoaesthesia
</level3>
<level3>
Application site induration
</level3>
<level3>
Application site infection
</level3>
<level3>
Application site inflammation
</level3>
<level3>
Application site injury
</level3>
<level3>
Application site irritation
</level3>
<level3>
Application site ischaemia
</level3>
<level3>
Application site joint discomfort
</level3>
<level3>
Application site joint effusion
</level3>
<level3>
Application site joint erythema
</level3>
<level3>
Application site joint infection
</level3>
<level3>
Application site joint inflammation
</level3>
<level3>
Application site joint movement impairment
</level3>
<level3>
Application site joint pain
</level3>
<level3>
Application site joint swelling
</level3>
<level3>
Application site joint warmth
</level3>
<level3>
Application site laceration
</level3>
<level3>
Application site lymphadenopathy
</level3>
<level3>
Application site macule
</level3>
<level3>
Application site mass
</level3>
<level3>
Application site movement impairment
</level3>
<level3>
Application site necrosis
</level3>
<level3>
Application site nerve damage
</level3>
<level3>
Application site nodule
</level3>
<level3>
Application site odour
</level3>
<level3>
Application site oedema
</level3>
<level3>
Application site pain
</level3>
<level3>
Application site pallor
</level3>
<level3>
Application site papules
</level3>
<level3>
Application site paraesthesia
</level3>
<level3>
Application site perspiration
</level3>
<level3>
Application site phlebitis
</level3>
<level3>
Application site photosensitivity reaction
</level3>
<level3>
Application site plaque
</level3>
<level3>
Application site pruritus
</level3>
<level3>
Application site purpura
</level3>
<level3>
Application site pustules
</level3>
<level3>
Application site rash
</level3>
<level3>
Application site reaction
</level3>
<level3>
Application site recall reaction
</level3>
<level3>
Application site scab
</level3>
<level3>
Application site scar
</level3>
<level3>
Application site streaking
</level3>
<level3>
Application site swelling
</level3>
<level3>
Application site telangiectasia
</level3>
<level3>
Application site thrombosis
</level3>
<level3>
Application site ulcer
</level3>
<level3>
Application site urticaria
</level3>
<level3>
Application site vasculitis
</level3>
<level3>
Application site vesicles
</level3>
<level3>
Application site warmth
</level3>
<level3>
Application site wound
</level3>
<level3>
Instillation site abscess
</level3>
<level3>
Instillation site anaesthesia
</level3>
<level3>
Instillation site atrophy
</level3>
<level3>
Instillation site bruise
</level3>
<level3>
Instillation site burn
</level3>
<level3>
Instillation site coldness
</level3>
<level3>
Instillation site complication
</level3>
<level3>
Instillation site discharge
</level3>
<level3>
Instillation site discolouration
</level3>
<level3>
Instillation site discomfort
</level3>
<level3>
Instillation site dryness
</level3>
<level3>
Instillation site erosion
</level3>
<level3>
Instillation site erythema
</level3>
<level3>
Instillation site exfoliation
</level3>
<level3>
Instillation site foreign body sensation
</level3>
<level3>
Instillation site haematoma
</level3>
<level3>
Instillation site haemorrhage
</level3>
<level3>
Instillation site hyperaesthesia
</level3>
<level3>
Instillation site hypersensitivity
</level3>
<level3>
Instillation site hypoaesthesia
</level3>
<level3>
Instillation site induration
</level3>
<level3>
Instillation site infection
</level3>
<level3>
Instillation site inflammation
</level3>
<level3>
Instillation site irritation
</level3>
<level3>
Instillation site lacrimation
</level3>
<level3>
Instillation site necrosis
</level3>
<level3>
Instillation site nodule
</level3>
<level3>
Instillation site odour
</level3>
<level3>
Instillation site oedema
</level3>
<level3>
Instillation site pain
</level3>
<level3>
Instillation site papules
</level3>
<level3>
Instillation site paraesthesia
</level3>
<level3>
Instillation site pruritus
</level3>
<level3>
Instillation site pustules
</level3>
<level3>
Instillation site rash
</level3>
<level3>
Instillation site reaction
</level3>
<level3>
Instillation site scab
</level3>
<level3>
Instillation site swelling
</level3>
<level3>
Instillation site thrombosis
</level3>
<level3>
Instillation site ulcer
</level3>
<level3>
Instillation site urticaria
</level3>
<level3>
Instillation site vesicles
</level3>
<level3>
Instillation site warmth
</level3>
<level3>
Malabsorption from application site
</level3>
</level2>
<level2 name =" Implant and catheter site reactions">
<level3>
Catheter site abscess
</level3>
<level3>
Catheter site bruise
</level3>
<level3>
Catheter site calcification
</level3>
<level3>
Catheter site cellulitis
</level3>
<level3>
Catheter site coldness
</level3>
<level3>
Catheter site dermatitis
</level3>
<level3>
Catheter site discharge
</level3>
<level3>
Catheter site discolouration
</level3>
<level3>
Catheter site dryness
</level3>
<level3>
Catheter site eczema
</level3>
<level3>
Catheter site erosion
</level3>
<level3>
Catheter site erythema
</level3>
<level3>
Catheter site exfoliation
</level3>
<level3>
Catheter site extravasation
</level3>
<level3>
Catheter site fibrosis
</level3>
<level3>
Catheter site granuloma
</level3>
<level3>
Catheter site haematoma
</level3>
<level3>
Catheter site haemorrhage
</level3>
<level3>
Catheter site hypersensitivity
</level3>
<level3>
Catheter site hypertrophy
</level3>
<level3>
Catheter site hypoaesthesia
</level3>
<level3>
Catheter site induration
</level3>
<level3>
Catheter site infection
</level3>
<level3>
Catheter site inflammation
</level3>
<level3>
Catheter site injury
</level3>
<level3>
Catheter site ischaemia
</level3>
<level3>
Catheter site macule
</level3>
<level3>
Catheter site mass
</level3>
<level3>
Catheter site necrosis
</level3>
<level3>
Catheter site nodule
</level3>
<level3>
Catheter site oedema
</level3>
<level3>
Catheter site pain
</level3>
<level3>
Catheter site pallor
</level3>
<level3>
Catheter site papule
</level3>
<level3>
Catheter site paraesthesia
</level3>
<level3>
Catheter site phlebitis
</level3>
<level3>
Catheter site pruritus
</level3>
<level3>
Catheter site pustule
</level3>
<level3>
Catheter site rash
</level3>
<level3>
Catheter site related reaction
</level3>
<level3>
Catheter site scab
</level3>
<level3>
Catheter site scar
</level3>
<level3>
Catheter site swelling
</level3>
<level3>
Catheter site thrombosis
</level3>
<level3>
Catheter site ulcer
</level3>
<level3>
Catheter site urticaria
</level3>
<level3>
Catheter site vasculitis
</level3>
<level3>
Catheter site vesicles
</level3>
<level3>
Catheter site warmth
</level3>
<level3>
Implant site abscess
</level3>
<level3>
Implant site atrophy
</level3>
<level3>
Implant site bruising
</level3>
<level3>
Implant site calcification
</level3>
<level3>
Implant site cellulitis
</level3>
<level3>
Implant site coldness
</level3>
<level3>
Implant site cyst
</level3>
<level3>
Implant site dehiscence
</level3>
<level3>
Implant site dermatitis
</level3>
<level3>
Implant site discharge
</level3>
<level3>
Implant site discolouration
</level3>
<level3>
Implant site erosion
</level3>
<level3>
Implant site erythema
</level3>
<level3>
Implant site exfoliation
</level3>
<level3>
Implant site extravasation
</level3>
<level3>
Implant site fibrosis
</level3>
<level3>
Implant site haematoma
</level3>
<level3>
Implant site haemorrhage
</level3>
<level3>
Implant site hyperaesthesia
</level3>
<level3>
Implant site hypersensitivity
</level3>
<level3>
Implant site hypertrophy
</level3>
<level3>
Implant site hypoaesthesia
</level3>
<level3>
Implant site induration
</level3>
<level3>
Implant site infection
</level3>
<level3>
Implant site inflammation
</level3>
<level3>
Implant site irritation
</level3>
<level3>
Implant site ischaemia
</level3>
<level3>
Implant site mass
</level3>
<level3>
Implant site necrosis
</level3>
<level3>
Implant site nerve injury
</level3>
<level3>
Implant site nodule
</level3>
<level3>
Implant site oedema
</level3>
<level3>
Implant site pain
</level3>
<level3>
Implant site pallor
</level3>
<level3>
Implant site papules
</level3>
<level3>
Implant site paraesthesia
</level3>
<level3>
Implant site phlebitis
</level3>
<level3>
Implant site photosensitivity
</level3>
<level3>
Implant site pruritus
</level3>
<level3>
Implant site pustules
</level3>
<level3>
Implant site rash
</level3>
<level3>
Implant site reaction
</level3>
<level3>
Implant site scar
</level3>
<level3>
Implant site swelling
</level3>
<level3>
Implant site thrombosis
</level3>
<level3>
Implant site ulcer
</level3>
<level3>
Implant site urticaria
</level3>
<level3>
Implant site vesicles
</level3>
<level3>
Implant site warmth
</level3>
</level2>
<level2 name =" Infusion site reactions">
<level3>
Infusion site abscess
</level3>
<level3>
Infusion site abscess sterile
</level3>
<level3>
Infusion site anaesthesia
</level3>
<level3>
Infusion site atrophy
</level3>
<level3>
Infusion site bruising
</level3>
<level3>
Infusion site calcification
</level3>
<level3>
Infusion site cellulitis
</level3>
<level3>
Infusion site coldness
</level3>
<level3>
Infusion site cyst
</level3>
<level3>
Infusion site dermatitis
</level3>
<level3>
Infusion site discharge
</level3>
<level3>
Infusion site discolouration
</level3>
<level3>
Infusion site discomfort
</level3>
<level3>
Infusion site dryness
</level3>
<level3>
Infusion site dysaesthesia
</level3>
<level3>
Infusion site eczema
</level3>
<level3>
Infusion site erosion
</level3>
<level3>
Infusion site erythema
</level3>
<level3>
Infusion site exfoliation
</level3>
<level3>
Infusion site extravasation
</level3>
<level3>
Infusion site fibrosis
</level3>
<level3>
Infusion site granuloma
</level3>
<level3>
Infusion site haematoma
</level3>
<level3>
Infusion site haemorrhage
</level3>
<level3>
Infusion site hyperaesthesia
</level3>
<level3>
Infusion site hypersensitivity
</level3>
<level3>
Infusion site hypertrichosis
</level3>
<level3>
Infusion site hypertrophy
</level3>
<level3>
Infusion site hypoaesthesia
</level3>
<level3>
Infusion site induration
</level3>
<level3>
Infusion site infection
</level3>
<level3>
Infusion site inflammation
</level3>
<level3>
Infusion site injury
</level3>
<level3>
Infusion site irritation
</level3>
<level3>
Infusion site ischaemia
</level3>
<level3>
Infusion site joint discomfort
</level3>
<level3>
Infusion site joint effusion
</level3>
<level3>
Infusion site joint erythema
</level3>
<level3>
Infusion site joint infection
</level3>
<level3>
Infusion site joint inflammation
</level3>
<level3>
Infusion site joint movement impairment
</level3>
<level3>
Infusion site joint pain
</level3>
<level3>
Infusion site joint swelling
</level3>
<level3>
Infusion site joint warmth
</level3>
<level3>
Infusion site laceration
</level3>
<level3>
Infusion site lymphadenopathy
</level3>
<level3>
Infusion site macule
</level3>
<level3>
Infusion site mass
</level3>
<level3>
Infusion site mobility decreased
</level3>
<level3>
Infusion site necrosis
</level3>
<level3>
Infusion site nerve damage
</level3>
<level3>
Infusion site nodule
</level3>
<level3>
Infusion site oedema
</level3>
<level3>
Infusion site pain
</level3>
<level3>
Infusion site pallor
</level3>
<level3>
Infusion site papule
</level3>
<level3>
Infusion site paraesthesia
</level3>
<level3>
Infusion site phlebitis
</level3>
<level3>
Infusion site photosensitivity reaction
</level3>
<level3>
Infusion site plaque
</level3>
<level3>
Infusion site pruritus
</level3>
<level3>
Infusion site pustule
</level3>
<level3>
Infusion site rash
</level3>
<level3>
Infusion site reaction
</level3>
<level3>
Infusion site recall reaction
</level3>
<level3>
Infusion site scab
</level3>
<level3>
Infusion site scar
</level3>
<level3>
Infusion site streaking
</level3>
<level3>
Infusion site swelling
</level3>
<level3>
Infusion site thrombosis
</level3>
<level3>
Infusion site ulcer
</level3>
<level3>
Infusion site urticaria
</level3>
<level3>
Infusion site vasculitis
</level3>
<level3>
Infusion site vesicles
</level3>
<level3>
Infusion site warmth
</level3>
</level2>
<level2 name =" Injection site reactions">
<level3>
Embolia cutis medicamentosa
</level3>
<level3>
Injected limb mobility decreased
</level3>
<level3>
Injection site abscess
</level3>
<level3>
Injection site abscess sterile
</level3>
<level3>
Injection site anaesthesia
</level3>
<level3>
Injection site atrophy
</level3>
<level3>
Injection site bruising
</level3>
<level3>
Injection site calcification
</level3>
<level3>
Injection site cellulitis
</level3>
<level3>
Injection site coldness
</level3>
<level3>
Injection site cyst
</level3>
<level3>
Injection site deformation
</level3>
<level3>
Injection site dermatitis
</level3>
<level3>
Injection site discharge
</level3>
<level3>
Injection site discolouration
</level3>
<level3>
Injection site discomfort
</level3>
<level3>
Injection site dryness
</level3>
<level3>
Injection site dysaesthesia
</level3>
<level3>
Injection site eczema
</level3>
<level3>
Injection site erosion
</level3>
<level3>
Injection site erythema
</level3>
<level3>
Injection site exfoliation
</level3>
<level3>
Injection site extravasation
</level3>
<level3>
Injection site fibrosis
</level3>
<level3>
Injection site granuloma
</level3>
<level3>
Injection site haematoma
</level3>
<level3>
Injection site haemorrhage
</level3>
<level3>
Injection site hyperaesthesia
</level3>
<level3>
Injection site hypersensitivity
</level3>
<level3>
Injection site hypertrichosis
</level3>
<level3>
Injection site hypertrophy
</level3>
<level3>
Injection site hypoaesthesia
</level3>
<level3>
Injection site indentation
</level3>
<level3>
Injection site induration
</level3>
<level3>
Injection site infection
</level3>
<level3>
Injection site inflammation
</level3>
<level3>
Injection site injury
</level3>
<level3>
Injection site irritation
</level3>
<level3>
Injection site ischaemia
</level3>
<level3>
Injection site joint discomfort
</level3>
<level3>
Injection site joint effusion
</level3>
<level3>
Injection site joint erythema
</level3>
<level3>
Injection site joint infection
</level3>
<level3>
Injection site joint inflammation
</level3>
<level3>
Injection site joint movement impairment
</level3>
<level3>
Injection site joint pain
</level3>
<level3>
Injection site joint swelling
</level3>
<level3>
Injection site joint warmth
</level3>
<level3>
Injection site laceration
</level3>
<level3>
Injection site lymphadenopathy
</level3>
<level3>
Injection site macule
</level3>
<level3>
Injection site mass
</level3>
<level3>
Injection site movement impairment
</level3>
<level3>
Injection site necrosis
</level3>
<level3>
Injection site nerve damage
</level3>
<level3>
Injection site nodule
</level3>
<level3>
Injection site oedema
</level3>
<level3>
Injection site pain
</level3>
<level3>
Injection site pallor
</level3>
<level3>
Injection site papule
</level3>
<level3>
Injection site paraesthesia
</level3>
<level3>
Injection site phlebitis
</level3>
<level3>
Injection site photosensitivity reaction
</level3>
<level3>
Injection site plaque
</level3>
<level3>
Injection site pruritus
</level3>
<level3>
Injection site pustule
</level3>
<level3>
Injection site rash
</level3>
<level3>
Injection site reaction
</level3>
<level3>
Injection site recall reaction
</level3>
<level3>
Injection site scab
</level3>
<level3>
Injection site scar
</level3>
<level3>
Injection site streaking
</level3>
<level3>
Injection site swelling
</level3>
<level3>
Injection site telangiectasia
</level3>
<level3>
Injection site thrombosis
</level3>
<level3>
Injection site ulcer
</level3>
<level3>
Injection site urticaria
</level3>
<level3>
Injection site vasculitis
</level3>
<level3>
Injection site vesicles
</level3>
<level3>
Injection site warmth
</level3>
<level3>
Malabsorption from injection site
</level3>
</level2>
<level2 name =" Vaccination site reactions">
<level3>
Extensive swelling of vaccinated limb
</level3>
<level3>
Robust take following exposure to vaccinia virus
</level3>
<level3>
Vaccination site abscess
</level3>
<level3>
Vaccination site abscess sterile
</level3>
<level3>
Vaccination site anaesthesia
</level3>
<level3>
Vaccination site atrophy
</level3>
<level3>
Vaccination site bruising
</level3>
<level3>
Vaccination site calcification
</level3>
<level3>
Vaccination site cellulitis
</level3>
<level3>
Vaccination site coldness
</level3>
<level3>
Vaccination site cyst
</level3>
<level3>
Vaccination site dermatitis
</level3>
<level3>
Vaccination site discharge
</level3>
<level3>
Vaccination site discolouration
</level3>
<level3>
Vaccination site discomfort
</level3>
<level3>
Vaccination site dryness
</level3>
<level3>
Vaccination site dysaesthesia
</level3>
<level3>
Vaccination site eczema
</level3>
<level3>
Vaccination site erosion
</level3>
<level3>
Vaccination site erythema
</level3>
<level3>
Vaccination site eschar
</level3>
<level3>
Vaccination site exfoliation
</level3>
<level3>
Vaccination site extravasation
</level3>
<level3>
Vaccination site fibrosis
</level3>
<level3>
Vaccination site granuloma
</level3>
<level3>
Vaccination site haematoma
</level3>
<level3>
Vaccination site haemorrhage
</level3>
<level3>
Vaccination site hyperaesthesia
</level3>
<level3>
Vaccination site hypersensitivity
</level3>
<level3>
Vaccination site hypertrichosis
</level3>
<level3>
Vaccination site hypertrophy
</level3>
<level3>
Vaccination site hypoaesthesia
</level3>
<level3>
Vaccination site induration
</level3>
<level3>
Vaccination site infection
</level3>
<level3>
Vaccination site inflammation
</level3>
<level3>
Vaccination site injury
</level3>
<level3>
Vaccination site irritation
</level3>
<level3>
Vaccination site ischaemia
</level3>
<level3>
Vaccination site joint discomfort
</level3>
<level3>
Vaccination site joint effusion
</level3>
<level3>
Vaccination site joint erythema
</level3>
<level3>
Vaccination site joint infection
</level3>
<level3>
Vaccination site joint inflammation
</level3>
<level3>
Vaccination site joint movement impairment
</level3>
<level3>
Vaccination site joint pain
</level3>
<level3>
Vaccination site joint swelling
</level3>
<level3>
Vaccination site joint warmth
</level3>
<level3>
Vaccination site laceration
</level3>
<level3>
Vaccination site lymphadenopathy
</level3>
<level3>
Vaccination site macule
</level3>
<level3>
Vaccination site mass
</level3>
<level3>
Vaccination site movement impairment
</level3>
<level3>
Vaccination site necrosis
</level3>
<level3>
Vaccination site nerve damage
</level3>
<level3>
Vaccination site nodule
</level3>
<level3>
Vaccination site oedema
</level3>
<level3>
Vaccination site pain
</level3>
<level3>
Vaccination site pallor
</level3>
<level3>
Vaccination site papule
</level3>
<level3>
Vaccination site paraesthesia
</level3>
<level3>
Vaccination site phlebitis
</level3>
<level3>
Vaccination site photosensitivity reaction
</level3>
<level3>
Vaccination site plaque
</level3>
<level3>
Vaccination site pruritus
</level3>
<level3>
Vaccination site pustule
</level3>
<level3>
Vaccination site rash
</level3>
<level3>
Vaccination site reaction
</level3>
<level3>
Vaccination site recall reaction
</level3>
<level3>
Vaccination site scab
</level3>
<level3>
Vaccination site scar
</level3>
<level3>
Vaccination site streaking
</level3>
<level3>
Vaccination site swelling
</level3>
<level3>
Vaccination site thrombosis
</level3>
<level3>
Vaccination site ulcer
</level3>
<level3>
Vaccination site urticaria
</level3>
<level3>
Vaccination site vasculitis
</level3>
<level3>
Vaccination site vesicles
</level3>
<level3>
Vaccination site warmth
</level3>
</level2>
</level1>
<level1 name =" Body temperature conditions">
<level2 name =" Body temperature altered">
<level3>
Disturbance of thermoregulation of newborn
</level3>
<level3>
Hyperthermia
</level3>
<level3>
Hyperthermia malignant
</level3>
<level3>
Hypothermia
</level3>
<level3>
Hypothermia neonatal
</level3>
<level3>
Neuroleptic malignant syndrome
</level3>
<level3>
Temperature regulation disorder
</level3>
</level2>
<level2 name =" Febrile disorders">
<level3>
Autoinflammatory disease
</level3>
<level3>
Chronic infantile neurological cutaneous and articular syndrome
</level3>
<level3>
Cryopyrin associated periodic syndrome
</level3>
<level3>
Cytarabine syndrome
</level3>
<level3>
Deficiency of the interleukin-1 receptor antagonist
</level3>
<level3>
Deficiency of the interleukin-36 receptor antagonist
</level3>
<level3>
Delirium febrile
</level3>
<level3>
Familial cold autoinflammatory syndrome
</level3>
<level3>
Familial mediterranean fever
</level3>
<level3>
Febrile bone marrow aplasia
</level3>
<level3>
Febrile convulsion
</level3>
<level3>
Febrile infection
</level3>
<level3>
Febrile neutropenia
</level3>
<level3>
Febrile nonhaemolytic transfusion reaction
</level3>
<level3>
Fever neonatal
</level3>
<level3>
Hyper IgD syndrome
</level3>
<level3>
Hyperpyrexia
</level3>
<level3>
Majeed's syndrome
</level3>
<level3>
Masked fever
</level3>
<level3>
Metal fume fever
</level3>
<level3>
Mevalonate kinase deficiency
</level3>
<level3>
Mevalonic aciduria
</level3>
<level3>
Middle East respiratory syndrome
</level3>
<level3>
PFAPA syndrome
</level3>
<level3>
Polymer fume fever
</level3>
<level3>
Postoperative fever
</level3>
<level3>
Puerperal pyrexia
</level3>
<level3>
Pyrexia
</level3>
<level3>
Schnitzler's syndrome
</level3>
<level3>
Severe acute respiratory syndrome
</level3>
<level3>
Still's disease
</level3>
<level3>
Tumour necrosis factor receptor-associated periodic syndrome
</level3>
</level2>
</level1>
<level1 name =" Complications associated with device">
<level2 name =" Breast complications associated with device">
<level3>
Breast complication associated with device
</level3>
<level3>
Capsular contracture associated with breast implant
</level3>
<level3>
Symmastia
</level3>
</level2>
<level2 name =" Cardiac complications associated with device">
<level3>
Cardiac complication associated with device
</level3>
<level3>
Cardiac valve replacement complication
</level3>
<level3>
Dilatation of sinotubular junction
</level3>
<level3>
Pacemaker generated arrhythmia
</level3>
<level3>
Pacemaker syndrome
</level3>
<level3>
Paravalvular aortic regurgitation
</level3>
</level2>
<level2 name =" Complications associated with device NEC">
<level3>
Allergy to surgical sutures
</level3>
<level3>
Cardiac haemolytic anaemia
</level3>
<level3>
Complication associated with device
</level3>
<level3>
Complication of device insertion
</level3>
<level3>
Complication of device removal
</level3>
<level3>
Dental restoration failure
</level3>
<level3>
Device allergy
</level3>
<level3>
Device intolerance
</level3>
<level3>
Device psychogenic complication
</level3>
<level3>
Device related infection
</level3>
<level3>
Device related sepsis
</level3>
<level3>
Device toxicity
</level3>
<level3>
Gastrointestinal complication associated with device
</level3>
<level3>
Injury associated with device
</level3>
<level3>
Medical device discomfort
</level3>
<level3>
Medical device pain
</level3>
<level3>
Medical device site abscess
</level3>
<level3>
Medical device site anaesthesia
</level3>
<level3>
Medical device site atrophy
</level3>
<level3>
Medical device site bruise
</level3>
<level3>
Medical device site burn
</level3>
<level3>
Medical device site calcification
</level3>
<level3>
Medical device site cellulitis
</level3>
<level3>
Medical device site coldness
</level3>
<level3>
Medical device site cyst
</level3>
<level3>
Medical device site dermatitis
</level3>
<level3>
Medical device site discharge
</level3>
<level3>
Medical device site discolouration
</level3>
<level3>
Medical device site discomfort
</level3>
<level3>
Medical device site dryness
</level3>
<level3>
Medical device site dysaesthesia
</level3>
<level3>
Medical device site eczema
</level3>
<level3>
Medical device site erosion
</level3>
<level3>
Medical device site erythema
</level3>
<level3>
Medical device site exfoliation
</level3>
<level3>
Medical device site extravasation
</level3>
<level3>
Medical device site fibrosis
</level3>
<level3>
Medical device site granuloma
</level3>
<level3>
Medical device site haematoma
</level3>
<level3>
Medical device site haemorrhage
</level3>
<level3>
Medical device site hyperaesthesia
</level3>
<level3>
Medical device site hyperhidrosis
</level3>
<level3>
Medical device site hyperkeratosis
</level3>
<level3>
Medical device site hypersensitivity
</level3>
<level3>
Medical device site hypertrichosis
</level3>
<level3>
Medical device site hypertrophy
</level3>
<level3>
Medical device site hypoaesthesia
</level3>
<level3>
Medical device site induration
</level3>
<level3>
Medical device site infection
</level3>
<level3>
Medical device site inflammation
</level3>
<level3>
Medical device site injury
</level3>
<level3>
Medical device site irritation
</level3>
<level3>
Medical device site ischaemia
</level3>
<level3>
Medical device site joint discomfort
</level3>
<level3>
Medical device site joint effusion
</level3>
<level3>
Medical device site joint erythema
</level3>
<level3>
Medical device site joint infection
</level3>
<level3>
Medical device site joint inflammation
</level3>
<level3>
Medical device site joint movement impairment
</level3>
<level3>
Medical device site joint pain
</level3>
<level3>
Medical device site joint swelling
</level3>
<level3>
Medical device site joint warmth
</level3>
<level3>
Medical device site laceration
</level3>
<level3>
Medical device site lymphadenopathy
</level3>
<level3>
Medical device site macule
</level3>
<level3>
Medical device site mass
</level3>
<level3>
Medical device site movement impairment
</level3>
<level3>
Medical device site necrosis
</level3>
<level3>
Medical device site nerve damage
</level3>
<level3>
Medical device site nodule
</level3>
<level3>
Medical device site odour
</level3>
<level3>
Medical device site oedema
</level3>
<level3>
Medical device site pain
</level3>
<level3>
Medical device site pallor
</level3>
<level3>
Medical device site papule
</level3>
<level3>
Medical device site paraesthesia
</level3>
<level3>
Medical device site phlebitis
</level3>
<level3>
Medical device site photosensitivity reaction
</level3>
<level3>
Medical device site plaque
</level3>
<level3>
Medical device site pruritus
</level3>
<level3>
Medical device site pustule
</level3>
<level3>
Medical device site rash
</level3>
<level3>
Medical device site reaction
</level3>
<level3>
Medical device site recall reaction
</level3>
<level3>
Medical device site scab
</level3>
<level3>
Medical device site scar
</level3>
<level3>
Medical device site sterile abscess
</level3>
<level3>
Medical device site streaking
</level3>
<level3>
Medical device site swelling
</level3>
<level3>
Medical device site thrombosis
</level3>
<level3>
Medical device site ulcer
</level3>
<level3>
Medical device site urticaria
</level3>
<level3>
Medical device site vasculitis
</level3>
<level3>
Medical device site vesicles
</level3>
<level3>
Medical device site warmth
</level3>
<level3>
Musculoskeletal complication associated with device
</level3>
<level3>
Neurological complication associated with device
</level3>
<level3>
Peri-implantitis
</level3>
<level3>
Phantom shocks
</level3>
<level3>
Purple urine bag syndrome
</level3>
<level3>
Radiolucency around implant
</level3>
<level3>
Red cell fragmentation syndrome
</level3>
<level3>
Vascular access complication
</level3>
<level3>
Vascular access site bruising
</level3>
<level3>
Vascular access site complication
</level3>
<level3>
Vascular access site haematoma
</level3>
<level3>
Vascular access site haemorrhage
</level3>
<level3>
Vascular access site infection
</level3>
<level3>
Vascular access site occlusion
</level3>
<level3>
Vascular access site pseudoaneurysm
</level3>
<level3>
Vascular access site rupture
</level3>
</level2>
<level2 name =" Eye complications associated with device">
<level3>
Contact lens acute red eye
</level3>
<level3>
Corneal epithelial microcysts
</level3>
<level3>
Corneal warpage
</level3>
<level3>
Eye complication associated with device
</level3>
<level3>
Pseudophakodonesis
</level3>
<level3>
Superior corneal epithelial arcuate lesion
</level3>
</level2>
<level2 name =" Reproductive complications associated with device">
<level3>
Ectopic pregnancy with contraceptive device
</level3>
<level3>
Pregnancy with contraceptive device
</level3>
<level3>
Reproductive complication associated with device
</level3>
</level2>
<level2 name =" Respiratory complications associated with device">
<level3>
Endotracheal intubation complication
</level3>
<level3>
Respiratory complication associated with device
</level3>
<level3>
Tracheomalacia
</level3>
</level2>
<level2 name =" Vascular complications associated with device">
<level3>
Aortic perforation
</level3>
<level3>
Aortic restenosis
</level3>
<level3>
Arterial perforation
</level3>
<level3>
Arterial restenosis
</level3>
<level3>
Artificial blood vessel occlusion
</level3>
<level3>
Basilar artery perforation
</level3>
<level3>
Carotid artery perforation
</level3>
<level3>
Carotid artery restenosis
</level3>
<level3>
Cerebral artery perforation
</level3>
<level3>
Cerebral artery restenosis
</level3>
<level3>
Coronary artery restenosis
</level3>
<level3>
Device embolisation
</level3>
<level3>
Device related thrombosis
</level3>
<level3>
Femoral artery perforation
</level3>
<level3>
Femoral vein perforation
</level3>
<level3>
Iliac artery perforation
</level3>
<level3>
Iliac vein perforation
</level3>
<level3>
Inferior vena cava perforation
</level3>
<level3>
Lower limb artery perforation
</level3>
<level3>
Peripheral artery restenosis
</level3>
<level3>
Renal artery perforation
</level3>
<level3>
Splenic artery perforation
</level3>
<level3>
Stent-graft endoleak
</level3>
<level3>
Subclavian artery perforation
</level3>
<level3>
Subclavian vein perforation
</level3>
<level3>
Superior vena cava perforation
</level3>
<level3>
Vascular access malfunction
</level3>
<level3>
Vascular access site dissection
</level3>
<level3>
Vascular access site pain
</level3>
<level3>
Vascular access site rash
</level3>
<level3>
Vascular access site swelling
</level3>
<level3>
Vascular access site thrombosis
</level3>
<level3>
Vascular complication associated with device
</level3>
<level3>
Vascular stent infection
</level3>
<level3>
Vascular stent occlusion
</level3>
<level3>
Vascular stent restenosis
</level3>
<level3>
Vascular stent stenosis
</level3>
<level3>
Vascular stent thrombosis
</level3>
<level3>
Venous perforation
</level3>
<level3>
Vertebral artery perforation
</level3>
</level2>
</level1>
<level1 name =" Fatal outcomes">
<level2 name =" Death and sudden death">
<level3>
Accidental death
</level3>
<level3>
Agonal death struggle
</level3>
<level3>
Assisted suicide
</level3>
<level3>
Brain death
</level3>
<level3>
Cardiac death
</level3>
<level3>
Completed suicide
</level3>
<level3>
Death
</level3>
<level3>
Death neonatal
</level3>
<level3>
Decapitation
</level3>
<level3>
Drowning
</level3>
<level3>
Electrocution
</level3>
<level3>
Euthanasia
</level3>
<level3>
Foetal death
</level3>
<level3>
Maternal death affecting foetus
</level3>
<level3>
Maternal death during childbirth
</level3>
<level3>
Premature baby death
</level3>
<level3>
Stillbirth
</level3>
<level3>
Sudden cardiac death
</level3>
<level3>
Sudden death
</level3>
<level3>
Sudden infant death syndrome
</level3>
<level3>
Sudden unexplained death in epilepsy
</level3>
</level2>
</level1>
<level1 name =" General system disorders NEC">
<level2 name =" Acquired gene mutations and other alterations">
<level3>
Acquired gene mutation
</level3>
<level3>
Acquired mitochondrial DNA deletion
</level3>
<level3>
Acquired mitochondrial DNA mutation
</level3>
<level3>
Anaplastic lymphoma kinase gene and nucleophosmin gene fusion overexpression
</level3>
<level3>
Anaplastic lymphoma kinase gene mutation
</level3>
<level3>
Androgen receptor gene overexpression
</level3>
<level3>
BLyS polymorphism
</level3>
<level3>
BRAF gene mutation
</level3>
<level3>
BRCA1 gene mutation
</level3>
<level3>
BRCA2 gene mutation
</level3>
<level3>
C-kit gene mutation
</level3>
<level3>
C-kit gene overexpression
</level3>
<level3>
Carbonic anhydrase gene mutation
</level3>
<level3>
CYP1A2 polymorphism
</level3>
<level3>
CYP2B6 polymorphism
</level3>
<level3>
CYP2C19 polymorphism
</level3>
<level3>
CYP2C9 polymorphism
</level3>
<level3>
CYP2D6 polymorphism
</level3>
<level3>
EGFR gene mutation
</level3>
<level3>
EGFR gene overexpression
</level3>
<level3>
Endothelial protein C receptor polymorphism
</level3>
<level3>
Genetic polymorphism
</level3>
<level3>
Genotoxicity
</level3>
<level3>
H-ras gene mutation
</level3>
<level3>
HER-2 protein overexpression
</level3>
<level3>
HER2 gene amplification
</level3>
<level3>
HERG gene mutation
</level3>
<level3>
Interleukin 28B polymorphism
</level3>
<level3>
Janus kinase 2 mutation
</level3>
<level3>
K-ras gene mutation
</level3>
<level3>
Methylenetetrahydrofolate reductase polymorphism
</level3>
<level3>
N-ras gene mutation
</level3>
<level3>
NAT1 polymorphism
</level3>
<level3>
NAT2 polymorphism
</level3>
<level3>
NUT gene mutation
</level3>
<level3>
Oestrogen receptor gene overexpression
</level3>
<level3>
Plasminogen activator inhibitor polymorphism
</level3>
<level3>
Platelet-derived growth factor receptor gene mutation
</level3>
<level3>
Platelet-derived growth factor receptor overexpression
</level3>
<level3>
Progesterone receptor gene overexpression
</level3>
<level3>
PTEN gene mutation
</level3>
<level3>
RET gene mutation
</level3>
<level3>
Thiopurine methyltransferase polymorphism
</level3>
<level3>
Transmembrane receptor tyrosine kinase overexpression
</level3>
<level3>
Tyrosine kinase mutation
</level3>
<level3>
UGT1A1 gene mutation
</level3>
<level3>
UGT1A1 gene polymorphism
</level3>
<level3>
Vascular endothelial growth factor overexpression
</level3>
<level3>
VKORC1 gene polymorphism
</level3>
</level2>
<level2 name =" Adverse effect absent">
<level3>
No adverse event
</level3>
</level2>
<level2 name =" Asthenic conditions">
<level3>
Adult failure to thrive
</level3>
<level3>
Asthenia
</level3>
<level3>
Autonomic nervous system imbalance
</level3>
<level3>
Cachexia
</level3>
<level3>
Chronic fatigue syndrome
</level3>
<level3>
Decreased activity
</level3>
<level3>
Fatigue
</level3>
<level3>
Lethargy
</level3>
<level3>
Listless
</level3>
<level3>
Malaise
</level3>
<level3>
Post treatment Lyme disease syndrome
</level3>
<level3>
Sluggishness
</level3>
</level2>
<level2 name =" Feelings and sensations NEC">
<level3>
Alcoholic hangover
</level3>
<level3>
Burning sensation
</level3>
<level3>
Chills
</level3>
<level3>
Decreased appetite
</level3>
<level3>
Early satiety
</level3>
<level3>
Feeling abnormal
</level3>
<level3>
Feeling cold
</level3>
<level3>
Feeling drunk
</level3>
<level3>
Feeling hot
</level3>
<level3>
Feeling jittery
</level3>
<level3>
Feeling of body temperature change
</level3>
<level3>
Feeling of relaxation
</level3>
<level3>
Hangover
</level3>
<level3>
Humidity intolerance
</level3>
<level3>
Hunger
</level3>
<level3>
Increased appetite
</level3>
<level3>
Peripheral coldness
</level3>
<level3>
Sensation of blood flow
</level3>
<level3>
Sensation of foreign body
</level3>
<level3>
Sense of oppression
</level3>
<level3>
Temperature intolerance
</level3>
<level3>
Thirst
</level3>
<level3>
Thirst decreased
</level3>
</level2>
<level2 name =" Gait disturbances">
<level3>
Ataxia
</level3>
<level3>
Cerebellar ataxia
</level3>
<level3>
Dentatorubral-pallidoluysian atrophy
</level3>
<level3>
Friedreich's ataxia
</level3>
<level3>
Gait apraxia
</level3>
<level3>
Gait deviation
</level3>
<level3>
Gait disturbance
</level3>
<level3>
Gait inability
</level3>
<level3>
Gait spastic
</level3>
<level3>
Joubert syndrome
</level3>
<level3>
Loss of control of legs
</level3>
<level3>
Parkinsonian gait
</level3>
<level3>
Spinocerebellar ataxia
</level3>
<level3>
Trendelenburg's symptom
</level3>
</level2>
<level2 name =" General signs and symptoms NEC">
<level3>
Adhesion
</level3>
<level3>
Administration related reaction
</level3>
<level3>
Apparent death
</level3>
<level3>
Autoresuscitation
</level3>
<level3>
Bloody discharge
</level3>
<level3>
Chronic disease
</level3>
<level3>
Cold sweat
</level3>
<level3>
Concomitant disease aggravated
</level3>
<level3>
Concomitant disease progression
</level3>
<level3>
Condition aggravated
</level3>
<level3>
Contrast media deposition
</level3>
<level3>
Crepitations
</level3>
<level3>
Critical illness
</level3>
<level3>
Crying
</level3>
<level3>
Dark circles under eyes
</level3>
<level3>
Deformity
</level3>
<level3>
Developmental delay
</level3>
<level3>
Developmental regression
</level3>
<level3>
Disease complication
</level3>
<level3>
Disease prodromal stage
</level3>
<level3>
Disease progression
</level3>
<level3>
Disease recurrence
</level3>
<level3>
Disease susceptibility
</level3>
<level3>
Disuse syndrome
</level3>
<level3>
Dysstasia
</level3>
<level3>
Effusion
</level3>
<level3>
Energy increased
</level3>
<level3>
Exercise tolerance decreased
</level3>
<level3>
Exercise tolerance increased
</level3>
<level3>
Extravasation
</level3>
<level3>
Fat tissue decreased
</level3>
<level3>
Fat tissue increased
</level3>
<level3>
Fistula discharge
</level3>
<level3>
Fistula inflammation
</level3>
<level3>
Flushing
</level3>
<level3>
Foaming at mouth
</level3>
<level3>
General physical health deterioration
</level3>
<level3>
General symptom
</level3>
<level3>
Glassy eyes
</level3>
<level3>
Hot flush
</level3>
<level3>
Hyperhidrosis
</level3>
<level3>
Hypohidrosis
</level3>
<level3>
Ill-defined disorder
</level3>
<level3>
Impaired self-care
</level3>
<level3>
Induration
</level3>
<level3>
Infected fistula
</level3>
<level3>
Influenza like illness
</level3>
<level3>
Infusion related reaction
</level3>
<level3>
Injection related reaction
</level3>
<level3>
Irritability
</level3>
<level3>
Irritability postvaccinal
</level3>
<level3>
Local reaction
</level3>
<level3>
Macrosomia
</level3>
<level3>
Meteoropathy
</level3>
<level3>
Microlithiasis
</level3>
<level3>
Microsomia
</level3>
<level3>
Moaning
</level3>
<level3>
Mobility decreased
</level3>
<level3>
Multi-organ disorder
</level3>
<level3>
Multimorbidity
</level3>
<level3>
Multiple organ dysfunction syndrome
</level3>
<level3>
Neonatal multi-organ failure
</level3>
<level3>
Night sweats
</level3>
<level3>
Nonspecific reaction
</level3>
<level3>
Obstruction
</level3>
<level3>
Organ failure
</level3>
<level3>
Pallor
</level3>
<level3>
Perforation
</level3>
<level3>
Performance status decreased
</level3>
<level3>
Peripheral swelling
</level3>
<level3>
Pneumatosis
</level3>
<level3>
Post cardiac arrest syndrome
</level3>
<level3>
Pre-existing condition improved
</level3>
<level3>
Pre-existing disease
</level3>
<level3>
Premature ageing
</level3>
<level3>
Prolapse
</level3>
<level3>
Pseudocyst
</level3>
<level3>
Purulent discharge
</level3>
<level3>
Secretion discharge
</level3>
<level3>
Sensitivity to weather change
</level3>
<level3>
Serum sickness-like reaction
</level3>
<level3>
Sick building syndrome
</level3>
<level3>
Stenosis
</level3>
<level3>
Swelling
</level3>
<level3>
Symptom masked
</level3>
<level3>
Symptom recurrence
</level3>
<level3>
Terminal agitation
</level3>
<level3>
Terminal state
</level3>
<level3>
Thumb sucking
</level3>
<level3>
Tissue anoxia
</level3>
<level3>
Tissue discolouration
</level3>
<level3>
Unevaluable event
</level3>
<level3>
Unmasking of previously unidentified disease
</level3>
<level3>
Wound secretion
</level3>
<level3>
Xerosis
</level3>
<level3>
Yellow skin
</level3>
</level2>
<level2 name =" Hernias NEC">
<level3>
Hernia
</level3>
<level3>
Hernia congenital
</level3>
<level3>
Hernia obstructive
</level3>
<level3>
Hernia perforation
</level3>
<level3>
Incarcerated hernia
</level3>
<level3>
Postoperative hernia
</level3>
<level3>
Strangulated hernia
</level3>
</level2>
<level2 name =" Inflammations">
<level3>
Abscess sterile
</level3>
<level3>
Acute phase reaction
</level3>
<level3>
Diapedesis
</level3>
<level3>
Foreign body reaction
</level3>
<level3>
Granuloma
</level3>
<level3>
Inflammation
</level3>
<level3>
Inflammation masked
</level3>
<level3>
Inflammation of wound
</level3>
<level3>
Inflammatory pseudotumour
</level3>
<level3>
Lipogranuloma
</level3>
<level3>
Malnutrition-inflammation-atherosclerosis syndrome
</level3>
<level3>
Multicentric reticulohistiocytosis
</level3>
<level3>
Papillitis
</level3>
<level3>
Polyserositis
</level3>
<level3>
Post embolisation syndrome
</level3>
<level3>
Pseudopolyp
</level3>
<level3>
Pseudosepsis
</level3>
<level3>
Red breast syndrome
</level3>
<level3>
Sensitisation
</level3>
<level3>
Serositis
</level3>
<level3>
Soft tissue inflammation
</level3>
<level3>
Stoma site inflammation
</level3>
<level3>
Systemic inflammatory response syndrome
</level3>
<level3>
Vascular access site inflammation
</level3>
<level3>
Vestibulitis
</level3>
</level2>
<level2 name =" Mucosal findings abnormal">
<level3>
Burning sensation mucosal
</level3>
<level3>
Drug eruption
</level3>
<level3>
Enanthema
</level3>
<level3>
Erythroplasia
</level3>
<level3>
Fixed eruption
</level3>
<level3>
Leukoplakia
</level3>
<level3>
Malignant polyp
</level3>
<level3>
Mucocutaneous haemorrhage
</level3>
<level3>
Mucosa vesicle
</level3>
<level3>
Mucosal atrophy
</level3>
<level3>
Mucosal discolouration
</level3>
<level3>
Mucosal dryness
</level3>
<level3>
Mucosal erosion
</level3>
<level3>
Mucosal excoriation
</level3>
<level3>
Mucosal exfoliation
</level3>
<level3>
Mucosal haemorrhage
</level3>
<level3>
Mucosal hyperaemia
</level3>
<level3>
Mucosal hypertrophy
</level3>
<level3>
Mucosal induration
</level3>
<level3>
Mucosal infection
</level3>
<level3>
Mucosal inflammation
</level3>
<level3>
Mucosal membrane hyperplasia
</level3>
<level3>
Mucosal necrosis
</level3>
<level3>
Mucosal pain
</level3>
<level3>
Mucosal pigmentation
</level3>
<level3>
Mucosal roughness
</level3>
<level3>
Mucosal toxicity
</level3>
<level3>
Mucosal ulceration
</level3>
<level3>
Mucous membrane disorder
</level3>
<level3>
Oedema mucosal
</level3>
<level3>
Paraesthesia mucosal
</level3>
<level3>
Polyp
</level3>
<level3>
Precancerous mucosal lesion
</level3>
</level2>
<level2 name =" Oedema NEC">
<level3>
Allergic oedema
</level3>
<level3>
Capillary leak syndrome
</level3>
<level3>
Face oedema
</level3>
<level3>
Generalised oedema
</level3>
<level3>
Gestational oedema
</level3>
<level3>
Gravitational oedema
</level3>
<level3>
Heat oedema
</level3>
<level3>
Localised oedema
</level3>
<level3>
Morbihan disease
</level3>
<level3>
Oedema
</level3>
<level3>
Oedema blister
</level3>
<level3>
Oedema due to cardiac disease
</level3>
<level3>
Oedema due to hepatic disease
</level3>
<level3>
Oedema due to renal disease
</level3>
<level3>
Oedema neonatal
</level3>
<level3>
Oedema peripheral
</level3>
<level3>
Peripheral oedema neonatal
</level3>
<level3>
Peritumoural oedema
</level3>
<level3>
Scleroedema
</level3>
<level3>
Stoma site oedema
</level3>
<level3>
Vascular access site oedema
</level3>
<level3>
Visceral oedema
</level3>
</level2>
<level2 name =" Pain and discomfort NEC">
<level3>
Amputation stump pain
</level3>
<level3>
Axillary pain
</level3>
<level3>
Breakthrough pain
</level3>
<level3>
Chest discomfort
</level3>
<level3>
Chest pain
</level3>
<level3>
Costovertebral angle tenderness
</level3>
<level3>
Craniocervical syndrome
</level3>
<level3>
Discomfort
</level3>
<level3>
Eagle's syndrome
</level3>
<level3>
Facial pain
</level3>
<level3>
First bite syndrome
</level3>
<level3>
Flank pain
</level3>
<level3>
Fracture pain
</level3>
<level3>
Hernia pain
</level3>
<level3>
Incision site pain
</level3>
<level3>
Inflammatory pain
</level3>
<level3>
Kinesiophobia
</level3>
<level3>
Loin pain haematuria syndrome
</level3>
<level3>
Non-cardiac chest pain
</level3>
<level3>
Nyctalgia
</level3>
<level3>
Pain
</level3>
<level3>
Paradoxical pain
</level3>
<level3>
Phantom pain
</level3>
<level3>
Post procedural discomfort
</level3>
<level3>
Post-traumatic pain
</level3>
<level3>
Premenstrual pain
</level3>
<level3>
Procedural pain
</level3>
<level3>
Pseudoangina
</level3>
<level3>
Radiation associated pain
</level3>
<level3>
Spinal pain
</level3>
<level3>
Stoma site discomfort
</level3>
<level3>
Stoma site pain
</level3>
<level3>
Suprapubic pain
</level3>
<level3>
Tenderness
</level3>
<level3>
Visceral pain
</level3>
</level2>
</level1>
<level1 name =" Therapeutic and nontherapeutic effects (excl toxicity)">
<level2 name =" Interactions">
<level3>
Alcohol interaction
</level3>
<level3>
Device interaction
</level3>
<level3>
Drug chemical incompatibility
</level3>
<level3>
Drug interaction
</level3>
<level3>
Drug physiologic incompatibility
</level3>
<level3>
Drug therapeutic incompatibility
</level3>
<level3>
Drug-device interaction
</level3>
<level3>
Drug-disease interaction
</level3>
<level3>
Food interaction
</level3>
<level3>
Herbal interaction
</level3>
<level3>
Inhibitory drug interaction
</level3>
<level3>
Labelled drug-disease interaction medication error
</level3>
<level3>
Labelled drug-drug interaction medication error
</level3>
<level3>
Labelled drug-food interaction medication error
</level3>
<level3>
Potentiating drug interaction
</level3>
<level3>
Radiation interaction
</level3>
<level3>
Therapeutic agent-diagnostic test interaction
</level3>
<level3>
Tobacco interaction
</level3>
<level3>
Tyramine reaction
</level3>
</level2>
<level2 name =" Therapeutic and nontherapeutic responses">
<level3>
Adverse drug reaction
</level3>
<level3>
Adverse event
</level3>
<level3>
Adverse event following immunisation
</level3>
<level3>
Adverse food reaction
</level3>
<level3>
Adverse reaction
</level3>
<level3>
Cytogenetic response
</level3>
<level3>
Dermal absorption impaired
</level3>
<level3>
Dermal absorption increased
</level3>
<level3>
Device effect decreased
</level3>
<level3>
Device effect delayed
</level3>
<level3>
Device effect incomplete
</level3>
<level3>
Device effect increased
</level3>
<level3>
Device effect variable
</level3>
<level3>
Device ineffective
</level3>
<level3>
Diet failure
</level3>
<level3>
Drug effect decreased
</level3>
<level3>
Drug effect delayed
</level3>
<level3>
Drug effect faster than expected
</level3>
<level3>
Drug effect incomplete
</level3>
<level3>
Drug effect increased
</level3>
<level3>
Drug effect prolonged
</level3>
<level3>
Drug effect variable
</level3>
<level3>
Drug effective for unapproved indication
</level3>
<level3>
Drug ineffective
</level3>
<level3>
Drug ineffective for unapproved indication
</level3>
<level3>
Drug intolerance
</level3>
<level3>
Drug resistance
</level3>
<level3>
Drug tolerance
</level3>
<level3>
Drug tolerance decreased
</level3>
<level3>
Drug tolerance increased
</level3>
<level3>
Enzyme induction
</level3>
<level3>
Enzyme inhibition
</level3>
<level3>
Fishbane reaction
</level3>
<level3>
Idiosyncratic drug reaction
</level3>
<level3>
Immediate post-injection reaction
</level3>
<level3>
Insulin sparing effect
</level3>
<level3>
Membrane stabilising effect
</level3>
<level3>
Multiple-drug resistance
</level3>
<level3>
Negative cardiac inotropic effect
</level3>
<level3>
No reaction on previous exposure to drug
</level3>
<level3>
Oestrogenic effect
</level3>
<level3>
Paradoxical drug reaction
</level3>
<level3>
Positive cardiac inotropic effect
</level3>
<level3>
Product intolerance
</level3>
<level3>
Reactogenicity event
</level3>
<level3>
Remission not achieved
</level3>
<level3>
Renin-angiotensin system inhibition
</level3>
<level3>
Similar reaction on previous exposure to drug
</level3>
<level3>
Subcutaneous drug absorption impaired
</level3>
<level3>
Surgical failure
</level3>
<level3>
Sympathomimetic effect
</level3>
<level3>
Tachyphylaxis
</level3>
<level3>
Therapeutic product effective for unapproved indication
</level3>
<level3>
Therapeutic product ineffective
</level3>
<level3>
Therapeutic product ineffective for unapproved indication
</level3>
<level3>
Therapeutic reaction time decreased
</level3>
<level3>
Therapeutic response changed
</level3>
<level3>
Therapeutic response decreased
</level3>
<level3>
Therapeutic response delayed
</level3>
<level3>
Therapeutic response increased
</level3>
<level3>
Therapeutic response prolonged
</level3>
<level3>
Therapeutic response shortened
</level3>
<level3>
Therapeutic response unexpected
</level3>
<level3>
Therapy naive
</level3>
<level3>
Therapy non-responder
</level3>
<level3>
Therapy partial responder
</level3>
<level3>
Therapy responder
</level3>
<level3>
Treatment failure
</level3>
<level3>
Vaccine positive rechallenge
</level3>
<level3>
Virologic failure
</level3>
</level2>
<level2 name =" Withdrawal and rebound effects">
<level3>
Abnormal withdrawal bleeding
</level3>
<level3>
Alcohol withdrawal syndrome
</level3>
<level3>
Anti-androgen withdrawal syndrome
</level3>
<level3>
Central nervous system immune reconstitution inflammatory response
</level3>
<level3>
Delirium tremens
</level3>
<level3>
Drug withdrawal convulsions
</level3>
<level3>
Drug withdrawal headache
</level3>
<level3>
Drug withdrawal syndrome
</level3>
<level3>
Drug withdrawal syndrome neonatal
</level3>
<level3>
Haemodynamic rebound
</level3>
<level3>
Immune reconstitution inflammatory syndrome
</level3>
<level3>
Immune reconstitution inflammatory syndrome associated Kaposi's sarcoma
</level3>
<level3>
Immune reconstitution inflammatory syndrome associated tuberculosis
</level3>
<level3>
Immune recovery uveitis
</level3>
<level3>
Medication overuse headache
</level3>
<level3>
Parkinsonism hyperpyrexia syndrome
</level3>
<level3>
Rebound atopic dermatitis
</level3>
<level3>
Rebound eczema
</level3>
<level3>
Rebound effect
</level3>
<level3>
Rebound nasal congestion
</level3>
<level3>
Rebound psoriasis
</level3>
<level3>
Rebound psychosis
</level3>
<level3>
Rebound tachycardia
</level3>
<level3>
Retroviral rebound syndrome
</level3>
<level3>
Steroid withdrawal syndrome
</level3>
<level3>
Tobacco withdrawal symptoms
</level3>
<level3>
Withdrawal arrhythmia
</level3>
<level3>
Withdrawal bleed
</level3>
<level3>
Withdrawal hepatitis
</level3>
<level3>
Withdrawal hypertension
</level3>
<level3>
Withdrawal syndrome
</level3>
</level2>
</level1>
<level1 name =" Tissue disorders NEC">
<level2 name =" Fibrosis NEC">
<level3>
Fibrosis
</level3>
<level3>
Pelvic fibrosis
</level3>
</level2>
<level2 name =" Healing abnormal NEC">
<level3>
Excessive granulation tissue
</level3>
<level3>
Impaired healing
</level3>
</level2>
<level2 name =" Mass conditions NEC">
<level3>
Choristoma
</level3>
<level3>
Congenital cyst
</level3>
<level3>
Cyst
</level3>
<level3>
Cyst rupture
</level3>
<level3>
Encapsulation reaction
</level3>
<level3>
Haemophilic pseudotumour
</level3>
<level3>
Haemorrhagic cyst
</level3>
<level3>
Infected seroma
</level3>
<level3>
Mandibular mass
</level3>
<level3>
Mass
</level3>
<level3>
Nodule
</level3>
<level3>
Pelvic mass
</level3>
<level3>
Pseudohernia
</level3>
<level3>
Retention cyst
</level3>
<level3>
Seroma
</level3>
</level2>
<level2 name =" Necrosis NEC">
<level3>
Cell death
</level3>
<level3>
Fat necrosis
</level3>
<level3>
Necrobiosis
</level3>
<level3>
Necrosis
</level3>
<level3>
Wound necrosis
</level3>
</level2>
<level2 name =" Trophic disorders">
<level3>
Abnormal organ growth
</level3>
<level3>
Aplasia
</level3>
<level3>
Atrophy
</level3>
<level3>
Calcification metastatic
</level3>
<level3>
Calcinosis
</level3>
<level3>
Dysplasia
</level3>
<level3>
Dystrophic calcification
</level3>
<level3>
Heteroplasia
</level3>
<level3>
Hyperplasia
</level3>
<level3>
Hypertrophy
</level3>
<level3>
Metaplasia
</level3>
<level3>
Postoperative heterotopic calcification
</level3>
</level2>
<level2 name =" Ulcers NEC">
<level3>
Perforated ulcer
</level3>
<level3>
Stoma site ulcer
</level3>
<level3>
Traumatic ulcer
</level3>
<level3>
Tumour ulceration
</level3>
<level3>
Ulcer
</level3>
<level3>
Ulcer haemorrhage
</level3>
</level2>
</level1>
</level0>
